Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 8 M6 M8 M9 M9 M 32 M Research & development ————— — Operating income 601 M1.02 B1.31 B1.51 B881 M 4.73 B Non-Operating Income, Total -326 M-14 M144 M-60 M-105 M -35 M Interest expense, net of interest capitalized 40 M41 M84 M82 M82 M 289 M Non-Operating Income, excl. Interest Expenses -366 M-55 M60 M-142 M-187 M -324 M Unusual income/expense ————— — Pretax income 682 M1.13 B1.43 B324 M947 M 3.83 B Equity in earnings -2 M-79 M-31 M-55 M-29 M -194 M Taxes -5 M15 M11 M31 M74 M 131 M Non-controlling/minority interest 02 M2 M2 M1 M 7 M After tax other income/expense ————— — Net income before discontinued operations -21 M40 M118 M128 M248 M 534 M Discontinued operations ————— — Net income -21 M40 M118 M128 M248 M 534 M Dilution adjustment 00000 0 Preferred dividends 4 M5 M4 M4 M4 M 17 M Diluted net income available to common stockholders -25 M35 M114 M124 M244 M 517 M Basic earnings per share (Basic EPS) -0.20.260.860.971.83 3.92 Diluted earnings per share (Diluted EPS) -0.20.260.850.971.78 3.86 Average basic shares outstanding 126 M133 M133 M131 M133 M — Diluted shares outstanding 126 M134 M139 M132 M139 M — EBITDA 806 M1.18 B1.49 B1.69 B1.05 B 5.42 B EBIT 601 M1.02 B1.31 B1.51 B881 M 4.73 B Cost of revenue 120 M124 M133 M133 M133 M 523 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 153 M158 M180 M174 M173 M 685 M